DoP releases “Common Guidelines on Pharma Innovation and Entrepreneurship” for academic institutions

In order to encourage innovation and research, and to facilitate the entrepreneurship in the National Institutes of Pharma Education and Research (NIPERs), the Department of Pharma (DoP), after considering the National Innovation and Startup Policy 2019, National IPR Policy 2016 and similar policies of other institutes/departments, has prepared ‘Common Guidelines on Pharma Innovation and Entrepreneurship’ for academic institutions under its control. The policy aims to transform the academic research into innovative and commercially applicable technologies/products; build strong ecosystem for nurturing creativity and entrepreneurial activities and contribute to self-reliant India mission (Aatmanirbhar Bharat).

The policy aims to:

• encourage the faculty/staff members and students to pursue entrepreneurship;
• formulate policies and foster an ecosystem to generate ideas across disciplines that can be transformed into successful technologies, products and services;
• establish a mechanism for technology development and technology transfer;
• create institutional framework for effective implementation, monitoring and evaluation of the policy; and
• promote pharma innovation and entrepreneurship to foster the unmet therapeutic, socially impactful technologies delivering benefits to mankind

The policy guidelines, finalised with the approval of Dr Mansukh Mandaviya, Minister for Chemicals and Fertilizers, have been forwarded to all NIPERs for taking up further steps for their speedy and effective implementation.